inPractice® - Efavirenz

Agents Used in Antiretroviral Therapy

Authors: Philip Grant, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 9/10/19 (What's New)

Summary

Efavirenz is indicated in combination with other antiretroviral agents for treatment of HIV infection^{[FDA Efavirenz]}
Efavirenz is dosed orally 600 mg once daily
Also available as part of a coformulation with emtricitabine/tenofovir DF as a 1-pill once-daily regimen

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Dermatologic Complications, Initial Antiretroviral Therapy, Pregnancy, Special Populations, Treatment Complications